サマリー

テストステロン補充療法の世界市場 2024-2028
テストステロン補充療法市場は、2023〜2028年に4億9767万米ドルの成長が予測され、予測期間中のCAGRは3.7%で加速すると予測されています。この調査レポートは、テストステロン補充療法市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、人々の性腺機能低下症に対する認識を高める取り組みの高まり、慢性疾患の有病率の上昇、高齢化人口と閉経後女性の増加が牽引しています。
Technavioのテストステロン補充療法市場は以下のように区分される：
流通チャネル別
- 病院
- 小売
- オンライン
製品別
- 注射剤
- 外用剤
- その他
地域別
- 北米
- 欧州
- アジア
- その他の地域（ROW）
本調査では、テストステロン補充療法の新規治療アプローチの増加が、今後数年間のテストステロン補充療法市場の成長を促進する主要な理由の1つであると特定しています。また、患者支援プログラムの増加やテストステロン補充療法市場の進歩の増加は、市場の大きな需要につながります。
テストステロン補充療法市場に関するレポートは以下の分野をカバーしています：
- テストステロン補充療法市場のサイジング
- テストステロン補充療法市場の予測
- テストステロン補充療法市場の産業分析
強固なベンダー分析は、顧客が市場での地位を向上させるのに役立つように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Acerus Pharmaceuticals Corp.、Actiza Pharmaceutical Pvt.Ltd. 、Alembic Pharmaceuticals Ltd.、Amneal Pharmaceuticals Inc、Amneal Pharmaceuticals Inc.、Bausch Health Companies Inc.、Bayer AG、Cipla Ltd.、Eli Lilly and Co.、Endo International Plc、Ferring BV、Halozyme Therapeutics Inc.、Insud Pharma S.L.、Lupin Ltd.、Marius Pharmaceuticals、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.、Acrux Ltd.、Alvogen Iceland ehf、Sawai Pharmaceutical Co.沢井製薬株式会社。また、テストステロン補充療法市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/testosterone-replacement-therapy-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global testosterone replacement therapy market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global testosterone replacement therapy market 2018 - 2022 ($ million)
o 4.2 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.3 Product Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospitals - Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
o 6.4 Retail - Market size and forecast 2023-2028
o Exhibit 38: Chart on Retail - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Retail - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Retail - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
o 6.5 Online - Market size and forecast 2023-2028
o Exhibit 42: Chart on Online - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Online - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Online - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Online - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 48: Chart on Product - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
o 7.2 Comparison by Product
o Exhibit 50: Chart on Comparison by Product
o Exhibit 51: Data Table on Comparison by Product
o 7.3 Injectables - Market size and forecast 2023-2028
o Exhibit 52: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Injectables - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
o 7.4 Topicals - Market size and forecast 2023-2028
o Exhibit 56: Chart on Topicals - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Topicals - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Topicals - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
o 7.5 Others - Market size and forecast 2023-2028
o Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Product
o Exhibit 64: Market opportunity by Product ($ million)
o Exhibit 65: Data Table on Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Canada - Market size and forecast 2023-2028
o Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 China - Market size and forecast 2023-2028
o Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. - Overview
o Exhibit 116: AbbVie Inc. - Product / Service
o Exhibit 117: AbbVie Inc. - Key news
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 Acerus Pharmaceuticals Corp.
o Exhibit 119: Acerus Pharmaceuticals Corp. - Overview
o Exhibit 120: Acerus Pharmaceuticals Corp. - Product / Service
o Exhibit 121: Acerus Pharmaceuticals Corp. - Key offerings
o 12.5 Alembic Pharmaceuticals Ltd.
o Exhibit 122: Alembic Pharmaceuticals Ltd. - Overview
o Exhibit 123: Alembic Pharmaceuticals Ltd. - Product / Service
o Exhibit 124: Alembic Pharmaceuticals Ltd. - Key offerings
o 12.6 Amneal Pharmaceuticals Inc.
o Exhibit 125: Amneal Pharmaceuticals Inc. - Overview
o Exhibit 126: Amneal Pharmaceuticals Inc. - Business segments
o Exhibit 127: Amneal Pharmaceuticals Inc. - Key news
o Exhibit 128: Amneal Pharmaceuticals Inc. - Key offerings
o Exhibit 129: Amneal Pharmaceuticals Inc. - Segment focus
o 12.7 Bausch Health Companies Inc.
o Exhibit 130: Bausch Health Companies Inc. - Overview
o Exhibit 131: Bausch Health Companies Inc. - Business segments
o Exhibit 132: Bausch Health Companies Inc. - Key news
o Exhibit 133: Bausch Health Companies Inc. - Key offerings
o Exhibit 134: Bausch Health Companies Inc. - Segment focus
o 12.8 Bayer AG
o Exhibit 135: Bayer AG - Overview
o Exhibit 136: Bayer AG - Business segments
o Exhibit 137: Bayer AG - Key news
o Exhibit 138: Bayer AG - Key offerings
o Exhibit 139: Bayer AG - Segment focus
o 12.9 Cipla Ltd.
o Exhibit 140: Cipla Ltd. - Overview
o Exhibit 141: Cipla Ltd. - Business segments
o Exhibit 142: Cipla Ltd. - Key news
o Exhibit 143: Cipla Ltd. - Key offerings
o Exhibit 144: Cipla Ltd. - Segment focus
o 12.10 Eli Lilly and Co.
o Exhibit 145: Eli Lilly and Co. - Overview
o Exhibit 146: Eli Lilly and Co. - Product / Service
o Exhibit 147: Eli Lilly and Co. - Key news
o Exhibit 148: Eli Lilly and Co. - Key offerings
o 12.11 Endo International Plc
o Exhibit 149: Endo International Plc - Overview
o Exhibit 150: Endo International Plc - Business segments
o Exhibit 151: Endo International Plc - Key news
o Exhibit 152: Endo International Plc - Key offerings
o Exhibit 153: Endo International Plc - Segment focus
o 12.12 Ferring BV
o Exhibit 154: Ferring BV - Overview
o Exhibit 155: Ferring BV - Product / Service
o Exhibit 156: Ferring BV - Key offerings
o 12.13 Halozyme Therapeutics Inc.
o Exhibit 157: Halozyme Therapeutics Inc. - Overview
o Exhibit 158: Halozyme Therapeutics Inc. - Product / Service
o Exhibit 159: Halozyme Therapeutics Inc. - Key offerings
o 12.14 Marius Pharmaceuticals
o Exhibit 160: Marius Pharmaceuticals - Overview
o Exhibit 161: Marius Pharmaceuticals - Product / Service
o Exhibit 162: Marius Pharmaceuticals - Key offerings
o 12.15 Pfizer Inc.
o Exhibit 163: Pfizer Inc. - Overview
o Exhibit 164: Pfizer Inc. - Product / Service
o Exhibit 165: Pfizer Inc. - Key news
o Exhibit 166: Pfizer Inc. - Key offerings
o 12.16 Sawai Pharmaceutical Co. Ltd.
o Exhibit 167: Sawai Pharmaceutical Co. Ltd. - Overview
o Exhibit 168: Sawai Pharmaceutical Co. Ltd. - Business segments
o Exhibit 169: Sawai Pharmaceutical Co. Ltd. - Key offerings
o Exhibit 170: Sawai Pharmaceutical Co. Ltd. - Segment focus
o 12.17 Teva Pharmaceutical Industries Ltd.
o Exhibit 171: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 172: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 175: Teva Pharmaceutical Industries Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 176: Inclusions checklist
o Exhibit 177: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 178: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 179: Research methodology
o Exhibit 180: Validation techniques employed for market sizing
o Exhibit 181: Information sources
o 13.5 List of abbreviations
o Exhibit 182: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global testosterone replacement therapy market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Retail - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Retail - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Product - Market share 2023-2028 (%)
Exhibits49: Data Table on Product - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Product
Exhibits51: Data Table on Comparison by Product
Exhibits52: Chart on Injectables - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Injectables - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Injectables - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Topicals - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Topicals - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Topicals - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Topicals - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Product ($ million)
Exhibits65: Data Table on Market opportunity by Product ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Acerus Pharmaceuticals Corp. - Overview
Exhibits120: Acerus Pharmaceuticals Corp. - Product / Service
Exhibits121: Acerus Pharmaceuticals Corp. - Key offerings
Exhibits122: Alembic Pharmaceuticals Ltd. - Overview
Exhibits123: Alembic Pharmaceuticals Ltd. - Product / Service
Exhibits124: Alembic Pharmaceuticals Ltd. - Key offerings
Exhibits125: Amneal Pharmaceuticals Inc. - Overview
Exhibits126: Amneal Pharmaceuticals Inc. - Business segments
Exhibits127: Amneal Pharmaceuticals Inc. - Key news
Exhibits128: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits129: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits130: Bausch Health Companies Inc. - Overview
Exhibits131: Bausch Health Companies Inc. - Business segments
Exhibits132: Bausch Health Companies Inc. - Key news
Exhibits133: Bausch Health Companies Inc. - Key offerings
Exhibits134: Bausch Health Companies Inc. - Segment focus
Exhibits135: Bayer AG - Overview
Exhibits136: Bayer AG - Business segments
Exhibits137: Bayer AG - Key news
Exhibits138: Bayer AG - Key offerings
Exhibits139: Bayer AG - Segment focus
Exhibits140: Cipla Ltd. - Overview
Exhibits141: Cipla Ltd. - Business segments
Exhibits142: Cipla Ltd. - Key news
Exhibits143: Cipla Ltd. - Key offerings
Exhibits144: Cipla Ltd. - Segment focus
Exhibits145: Eli Lilly and Co. - Overview
Exhibits146: Eli Lilly and Co. - Product / Service
Exhibits147: Eli Lilly and Co. - Key news
Exhibits148: Eli Lilly and Co. - Key offerings
Exhibits149: Endo International Plc - Overview
Exhibits150: Endo International Plc - Business segments
Exhibits151: Endo International Plc - Key news
Exhibits152: Endo International Plc - Key offerings
Exhibits153: Endo International Plc - Segment focus
Exhibits154: Ferring BV - Overview
Exhibits155: Ferring BV - Product / Service
Exhibits156: Ferring BV - Key offerings
Exhibits157: Halozyme Therapeutics Inc. - Overview
Exhibits158: Halozyme Therapeutics Inc. - Product / Service
Exhibits159: Halozyme Therapeutics Inc. - Key offerings
Exhibits160: Marius Pharmaceuticals - Overview
Exhibits161: Marius Pharmaceuticals - Product / Service
Exhibits162: Marius Pharmaceuticals - Key offerings
Exhibits163: Pfizer Inc. - Overview
Exhibits164: Pfizer Inc. - Product / Service
Exhibits165: Pfizer Inc. - Key news
Exhibits166: Pfizer Inc. - Key offerings
Exhibits167: Sawai Pharmaceutical Co. Ltd. - Overview
Exhibits168: Sawai Pharmaceutical Co. Ltd. - Business segments
Exhibits169: Sawai Pharmaceutical Co. Ltd. - Key offerings
Exhibits170: Sawai Pharmaceutical Co. Ltd. - Segment focus
Exhibits171: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits172: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits173: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits174: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits175: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Validation techniques employed for market sizing
Exhibits181: Information sources
Exhibits182: List of abbreviations